A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design.
about
Small molecule glucagon receptor antagonists: a patent review (2011 - 2014).Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn-Research-Confirm Process.Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes.Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).
P2860
A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A semi-mechanistic model for t ...... d to adaptive phase II design.
@ast
A semi-mechanistic model for t ...... d to adaptive phase II design.
@en
type
label
A semi-mechanistic model for t ...... d to adaptive phase II design.
@ast
A semi-mechanistic model for t ...... d to adaptive phase II design.
@en
prefLabel
A semi-mechanistic model for t ...... d to adaptive phase II design.
@ast
A semi-mechanistic model for t ...... d to adaptive phase II design.
@en
P2093
P2860
P1433
P1476
A semi-mechanistic model for t ...... ed to adaptive phase II design
@en
P2093
Aubrey Stoch
Bret J Musser
Joanna Z Peng
Julie A Stone
Ken G Kowalski
Kuenhi Tsai
Lanyan Fang
Matthew D Troyer
P2860
P2888
P304
P356
10.1208/S12248-014-9648-X
P407
P577
2014-08-27T00:00:00Z
P5875
P6179
1035367175